Education
About Us
Working with TipRanks
Follow Us
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
Total Valuation
MapLight Therapeutics, Inc. has a market cap or net worth of $810.36M. The enterprise value is $701.67M.
Market Cap$810.36M
Enterprise Value$701.67M
Share Statistics
MapLight Therapeutics, Inc. has 45,373,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,373,030
Owned by Insiders51.54%
Owned by Institutions―
Financial Efficiency
MapLight Therapeutics, Inc.’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -68.11%.
Return on Equity (ROE)-0.67
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-68.11%
Return on Capital Employed (ROCE)-0.69
Revenue Per Employee0.00
Profits Per Employee-711.74K
Employee Count109
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MapLight Therapeutics, Inc. is ―. MapLight Therapeutics, Inc.’s PEG ratio is -0.25.
PE Ratio―
PS Ratio0.00
PB Ratio6.60
Price to Fair Value6.60
Price to FCF-9.55
Price to Operating Cash Flow-7.04
PEG Ratio-0.25
Income Statement
In the last 12 months, MapLight Therapeutics, Inc. had revenue of 0.00 and earned -77.58M in profits. Earnings per share was -1.87.
Revenue0.00
Gross Profit-701.00K
Operating Income-82.95M
Pretax Income-77.58M
Net Income-77.58M
EBITDA-76.88M
Earnings Per Share (EPS)-1.87
Cash Flow
In the last 12 months, operating cash flow was -112.80M and capital expenditures -203.00K, giving a free cash flow of -113.00M billion.
Operating Cash Flow-112.80M
Free Cash Flow-113.00M
Free Cash Flow per Share-2.49
Dividends & Yields
MapLight Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)401.63K
Important Dates
MapLight Therapeutics, Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MapLight Therapeutics, Inc. as a current ratio of 7.20, with Debt / Equity ratio of 2.57%
Current Ratio7.20
Quick Ratio7.20
Debt to Market Cap<0.01
Net Debt to EBITDA0.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MapLight Therapeutics, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MapLight Therapeutics, Inc. EV to EBITDA ratio is -9.47, with an EV/FCF ratio of -9.15.
EV to Sales0.00
EV to EBITDA-9.47
EV to Free Cash Flow-9.15
EV to Operating Cash Flow-9.24
Balance Sheet
MapLight Therapeutics, Inc. has $227.17M in cash and marketable securities with $6.01M in debt, giving a net cash position of $221.16M billion.
Cash & Marketable Securities$227.17M
Total Debt$6.01M
Net Cash$221.16M
Net Cash Per Share$4.87
Tangible Book Value Per Share$2.78
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MapLight Therapeutics, Inc. is $31.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$31.00
Price Target Upside73.57% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―